Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Caris Life Sciences (CAI) Debt to Equity (2024 - 2025)

Caris Life Sciences (CAI) has 2 years of Debt to Equity data on record, last reported at $0.66 in Q4 2025.

  • For Q4 2025, Debt to Equity rose 532.23% year-over-year to $0.66; the TTM value through Dec 2025 reached $0.66, up 532.23%, while the annual FY2025 figure was $0.66, 532.23% up from the prior year.
  • Debt to Equity reached $0.66 in Q4 2025 per CAI's latest filing, down from $0.79 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.83 in Q2 2025 and bottomed at -$0.15 in Q4 2024.